BAD | BCL2-associated agonist of cell death | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
BARD1 | BRCA1 associated RING domain 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
BAX | BCL2-associated X protein | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BCL6 | B-cell CLL/lymphoma 6 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Group enriched |
BIRC2 | Baculoviral IAP repeat containing 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
BLMH | Bleomycin hydrolase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BMI1 | BMI1 proto-oncogene, polycomb ring finger | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BRD4 | Bromodomain containing 4 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Group enriched |
CA8 | Carbonic anhydrase VIII | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALR | Calreticulin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CANT1 | Calcium activated nucleotidase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CASP10 | Caspase 10, apoptosis-related cysteine peptidase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Mixed |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCNA2 | Cyclin A2 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CCND3 | Cyclin D3 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCNE2 | Cyclin E2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCNG1 | Cyclin G1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CD14 | CD14 molecule | Cancer-related genes CD markers Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD36 | CD36 molecule (thrombospondin receptor) | Cancer-related genes CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD38 | CD38 molecule | Cancer-related genes CD markers Enzymes Predicted intracellular proteins
| | | | | Mixed |
CD40 | CD40 molecule, TNF receptor superfamily member 5 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |